The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Low expression of gamma-glutamyl transpeptidase 1 is an independent poor prognostic factor in ovarian clear cell carcinoma, in relation to up-regulation of immune suppressive genes and EMT-related genes.
 
Hiroshi Asano
No Relationships to Disclose
 
Ryosuke Matsuoka
No Relationships to Disclose
 
Kanako C Hatanaka
Honoraria - AstraZeneca Japan (I); Chugai Pharma (I); Merck Sharp & Dohme (I); Novartis (I); Pfizer (I); Sysmex (I); Thermo Fisher Scientific (I)
Consulting or Advisory Role - Eisai (I); GeneticLab (I); Médicinal Chemistry Pharmaceutical (I)
Research Funding - Eisai (I); GeneticLab (I); Merck Sharp & Dohme (I); NB Health Laboratory; Roche (I); Sysmex (I); Taiho Pharmaceutical (I)
 
Daisuke Endo
No Relationships to Disclose
 
Ayako Nozaki
No Relationships to Disclose
 
Kei Ihira
No Relationships to Disclose
 
Takashi Mitamura
No Relationships to Disclose
 
Tatsuya Kato
No Relationships to Disclose
 
Yosuke Konno
No Relationships to Disclose
 
Yoshihiro Matsuno
No Relationships to Disclose
 
Yutaka Hatanaka
Honoraria - AstraZeneca Japan; Chugai Pharma; Merck Sharp & Dohme; Novartis; Pfizer; Sysmex; Thermo Fisher Scientific
Consulting or Advisory Role - Eisai; GeneticLab; Medicinal Chemistry Pharmaceutical
Research Funding - Eisai; Genetic Lab; Merck Sharp & Dohme; NB Health Laboratory; Roche; Sysmex; Taiho Pharmaceutical
 
Hidemichi Watari
No Relationships to Disclose